BANK VONTOBEL/CALL/MERCK & CO./115/0.1/20.09.24 Stock

Warrant

DE000VM7N412

Market Closed - Deutsche Boerse AG 14:00:52 2024-05-10 EDT
1.69 EUR +1.20% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./115/0.1/20.09.24
Current month-1.17%
1 month+13.42%
Date Price Change Volume
24-05-10 1.69 +1.20% 0
24-05-09 1.67 +1.83% 0
24-05-08 1.64 +3.80% 0
24-05-07 1.58 +6.76% 0
24-05-06 1.48 -1.33% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 02:00 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM7N41
ISINDE000VM7N412
Date issued 2023-12-29
Strike 115 $
Maturity 2024-09-20 (132 Days)
Parity 10 : 1
Emission price 0.54
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.97
Lowest since issue 0.5
Spread 0.01
Spread %0.60%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW